Xiaojing Dong

2.5k total citations · 1 hit paper
20 papers, 1.1k citations indexed

About

Xiaojing Dong is a scholar working on Infectious Diseases, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Xiaojing Dong has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 6 papers in Molecular Biology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Xiaojing Dong's work include SARS-CoV-2 and COVID-19 Research (8 papers), interferon and immune responses (5 papers) and COVID-19 Clinical Research Studies (4 papers). Xiaojing Dong is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (8 papers), interferon and immune responses (5 papers) and COVID-19 Clinical Research Studies (4 papers). Xiaojing Dong collaborates with scholars based in China, United States and Canada. Xiaojing Dong's co-authors include Jianwei Wang, Xiaobo Lei, Lili Ren, Xia Xiao, Zhuo Zhou, Zichun Xiang, Conghui Wang, Ying Wang, Zhendong Zhao and Fei Guo and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and International Journal of Hydrogen Energy.

In The Last Decade

Xiaojing Dong

20 papers receiving 1.1k citations

Hit Papers

Activation and evasion of type I interferon responses by ... 2020 2026 2022 2024 2020 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Activation and evasion of type I interferon responses by SARS-CoV-2
    2020 692 citations Xiaobo Lei, Xiaojing Dong et al. Nature Communications profile →

Peers

Xiaojing Dong
Conghui Wang China
Thiagarajan Venkataraman United States
Liu Cao China
Ruiyi Ma China
Thomas Kuri Germany
Lok-Yin Roy Wong United States
Adeline Heurich Germany
Kangtai Liu China
Conghui Wang China
Xiaojing Dong
Citations per year, relative to Xiaojing Dong Xiaojing Dong (= 1×) peers Conghui Wang

Countries citing papers authored by Xiaojing Dong

Since Specialization
Citations

This map shows the geographic impact of Xiaojing Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojing Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojing Dong more than expected).

Fields of papers citing papers by Xiaojing Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojing Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojing Dong. The network helps show where Xiaojing Dong may publish in the future.

Co-authorship network of co-authors of Xiaojing Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojing Dong. A scholar is included among the top collaborators of Xiaojing Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojing Dong. Xiaojing Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Nanyan, Mingze Zhang, Xin Pan, et al.. (2025). SNV/Indel and CNV Analysis in Trio‐WES for Intellectual and Developmental Disabilities: Diagnostic Yield & Cost‐Effectiveness. Clinical Genetics. 107(4). 402–412. 2 indexed citations
2.
Dong, Xiaojing, Yangyang Wang, Jintao Wang, et al.. (2024). Mn-doped RuO2 as superior pH-universal electrocatalyst for oxygen evolution reaction. International Journal of Hydrogen Energy. 73. 558–565. 7 indexed citations
3.
Huang, He, Xiaojing Dong, Li Guo, et al.. (2024). Administration of Lactobacillus plantarum GUANKE alleviates SARS-CoV-2-induced pneumonia in mice. Microbiology Spectrum. 12(12). e0160324–e0160324. 2 indexed citations
4.
Dong, Xiaojing, et al.. (2024). A First-Order, Semi-Implicit, and Unconditionally Energy-Stable Scheme for an Incompressible Ferrohydrodynamics Flow. Journal of Computational Mathematics. 43(4). 866–897. 3 indexed citations
5.
Dong, Xiaojing, et al.. (2023). Proteomic and phosphoproteomic analysis of responses to enterovirus A71 infection reveals novel targets for antiviral and viral replication. Antiviral Research. 220. 105761–105761. 6 indexed citations
6.
Pan, Xin, Sihan Liu, Li Liu, et al.. (2023). Whole exome sequencing and transcriptome analysis in two unrelated patients with novel SET mutations. Journal of Human Genetics. 68(12). 867–874. 2 indexed citations
7.
Dong, Xiaojing, et al.. (2023). Convergence Analysis of Some Finite Element Parallel Algorithms for the Stationary Incompressible MHD Equations. Journal of Computational Mathematics. 42(1). 49–70. 2 indexed citations
8.
Wang, Bei, Lan Chen, Hongtao Sui, et al.. (2023). The Environmental Stability of SARS-CoV-2 Variants Omicron BA.1 and BA.5 on the Surfaces of Widely Used Transport Packaging Materials. Microbiology Spectrum. 11(3). e0488122–e0488122. 1 indexed citations
9.
Dong, Xiaojing, Lan Chen, Xiaobo Lei, et al.. (2022). Screening for inhibitors against SARS-CoV-2 and its variants. Biosafety and Health. 4(3). 186–192. 5 indexed citations
10.
Dong, Xiaojing, Xia Xiao, Lili Ren, et al.. (2022). Gasdermin E is required for induction of pyroptosis and severe disease during enterovirus 71 infection. Journal of Biological Chemistry. 298(5). 101850–101850. 35 indexed citations
11.
Guo, Saisai, Xiaobo Lei, Yan Chang, et al.. (2022). SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis. Signal Transduction and Targeted Therapy. 7(1). 400–400. 11 indexed citations
12.
Chang, Le, Lei Zhao, Yan Xiao, et al.. (2022). Serosurvey for SARS-CoV-2 among blood donors in Wuhan, China from September to December 2019. Protein & Cell. 14(1). 28–36. 5 indexed citations
13.
Zhu, Yuanmei, Xiaojing Dong, Nian Liu, et al.. (2022). SARS-CoV-2 fusion-inhibitory lipopeptides maintain high potency against divergent variants of concern including Omicron. Emerging Microbes & Infections. 11(1). 1819–1827. 14 indexed citations
14.
Zhou, Zhuo, Xiaobo Lei, Xia Xiao, et al.. (2021). Sensing of cytoplasmic chromatin by cGAS activates innate immune response in SARS-CoV-2 infection. Signal Transduction and Targeted Therapy. 6(1). 382–382. 77 indexed citations
15.
Zhu, Shiyou, Ying Liu, Zhuo Zhou, et al.. (2021). Genome-wide CRISPR activation screen identifies candidate receptors for SARS-CoV-2 entry. Science China Life Sciences. 65(4). 701–717. 46 indexed citations
16.
Li, Quanjie, Dongrong Yi, Xiaobo Lei, et al.. (2021). Corilagin inhibits SARS-CoV-2 replication by targeting viral RNA-dependent RNA polymerase. Acta Pharmaceutica Sinica B. 11(6). 1555–1567. 56 indexed citations
17.
Wang, Wenjing, Zhuo Zhou, Xia Xiao, et al.. (2021). SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation. Cellular and Molecular Immunology. 18(4). 945–953. 105 indexed citations
18.
Zhang, Jiawen, Pingshuan Dong, Xiaojing Dong, et al.. (2021). Long-term changes in ischemic burden after chronic total occlusion percutaneous coronary intervention: a retrospective observational study.. PubMed. 13(7). 7632–7640. 1 indexed citations
19.
Lei, Xiaobo, Xiaojing Dong, Ruiyi Ma, et al.. (2020). Activation and evasion of type I interferon responses by SARS-CoV-2. Nature Communications. 11(1). 3810–3810. 692 indexed citations breakdown →
20.
Xiao, Xia, Conghui Wang, De Chang, et al.. (2020). Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2. Frontiers in Immunology. 11. 586572–586572. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Conghui Wang Breakdown of academic impact, for papers by Thiagarajan Venkataraman Breakdown of academic impact, for papers by Liu Cao Breakdown of academic impact, for papers by Ruiyi Ma Breakdown of academic impact, for papers by Thomas Kuri Breakdown of academic impact, for papers by Lok-Yin Roy Wong Breakdown of academic impact, for papers by Adeline Heurich Breakdown of academic impact, for papers by Kangtai Liu
Rankless by CCL
2026